Lactate's Role in Flap Ischemia and Fibrosis
Author Information
Author(s): Xu Yining, Ma Xianhui, Ni Weiyu, Zheng Lin, Lin Zhongnan, Lai Yingying, Yang Ningning, Dai Zhanqiu, Yao Teng, Chen Zeyang, Shen Lifeng, Wang Haitao, Wang Long, Wu Yizheng, Gao Weiyang
Primary Institution: Wenzhou Medical University
Hypothesis
Does lactate overproduction contribute to flap necrosis and its underlying mechanisms?
Conclusion
The study suggests that PKM2-derived lactate exacerbates flap fibrosis and ischemia by promoting endothelial-to-mesenchymal transition (EndoMT).
Supporting Evidence
- Endothelial-specific deletion of PKM2 reduces flap necrosis.
- Serum lactate levels correlate with flap ischemia severity.
- Lactate promotes EndoMT and fibrosis in endothelial cells.
- Twist1 lactylation is enhanced by lactate under hypoxic conditions.
- Twist1 overexpression worsens flap ischemia and fibrosis.
- PKM2-derived lactate activates TGF-β signaling.
- Silencing Twist1 mitigates lactate-induced EndoMT.
- Serum lactate levels may serve as a prognostic biomarker for flap ischemia.
Takeaway
Lactate, a substance produced when our body breaks down sugar for energy, can make skin flaps after surgery more likely to get damaged and scarred.
Methodology
The study involved RNA sequencing, in vivo and in vitro experiments, and various assays to assess lactate levels and cellular responses.
Potential Biases
Potential biases may arise from the selection of patient samples and the experimental design.
Limitations
The study primarily focuses on mouse models and may not fully translate to human conditions.
Participant Demographics
Patients undergoing flap transplantation surgeries, with varying degrees of ischemia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website